Yoshio KOWA
Yoshio KOWA publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Quinazolinone synthesis and applications, Metabolism and Genetic Disorders and Eicosanoids and Hypertension Pharmacology.
- World rank
- #7,183,174 of 7,710,434 ranked researchers
- Rank in United States
- #1,590,058 of 1,627,098
- Works
- 52
- Citations
- 234
- Citations per work
- 4.5
What does Yoshio KOWA research?
Yoshio KOWA's work is mostly in Chemistry (24%), Biochemistry, Genetics and Molecular Biology (16%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2344.6%
- Life Sciences1426.2%
- Physical Sciences1223.8%
- Chemistry1223.8%
- Health Sciences35.4%
- Medicine35.4%
- 1Organic Chemistry24% of their works
- 2Molecular Biology11% of their works
- 3Pharmacology6% of their works
- 4Biochemistry5% of their works
- 5Pharmacology5% of their works
- 6Cellular and Molecular Neuroscience4% of their works
Research topics
- Quinazolinone synthesis and applications
- Metabolism and Genetic Disorders
- Eicosanoids and Hypertension Pharmacology
- Pharmacological Effects of Natural Compounds
- Drug-Induced Hepatotoxicity and Protection
- Synthesis and Characterization of Heterocyclic Compounds
- Biopolymer Synthesis and Applications
- Phenothiazines and Benzothiazines Synthesis and Activities
Which keywords describe Yoshio KOWA's research?
The keywords of their largest research topics: Synthesis, Anticancer, Antimicrobial, Biological Evaluation, Inflammation, Indirubin, Quinazoline and Biochemical Genetics.
- Phenothiazines
- Biological Activities
- Licorice
- Glycyrrhizin
- Drug-Induced Liver Injury
- Arachidonic Acid
- Biochemical Genetics
- Indirubin
- Biological Evaluation
- Anticancer
- Synthesis
- Antimicrobial
- Inflammation
- Quinazoline
- Metabolic Disorders
- Drug Discovery
- Epoxyeicosatrienoic Acids
- Hepatotoxicity
- Triazines
- Microbial Production
- Polyglutamic Acid
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Synthesis174 topics
- Anticancer143 topics
- Antimicrobial143 topics
- Biological Evaluation112 topics
- Inflammation82 topics
- Indirubin71 topic
- Quinazoline71 topic
- Biochemical Genetics51 topic
- Metabolic Disorders51 topic
- Arachidonic Acid41 topic
- Drug Discovery41 topic
- Drug-Induced Liver Injury41 topic
- Epoxyeicosatrienoic Acids41 topic
- Glycyrrhizin41 topic
- Hepatotoxicity41 topic
- Licorice41 topic
- Triazines41 topic
- Biological Activities31 topic
- Microbial Production31 topic
- Phenothiazines31 topic
- Polyglutamic Acid31 topic
Where does Yoshio KOWA work?
Yoshio KOWA's main affiliation in the publication record is Tanabe Research Laboratories, United States.
How many publications and citations does Yoshio KOWA have?
OpenAlex counts 52 works and 234 citations for Yoshio KOWA, an h-index of 6, ranking #7,183,174 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yoshio KOWA. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.